Suzhou Fengbei Biotech Stock Co., Ltd. (SHA:603334)

SHA:603334 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	335.73	567.16	166.78	156.74	217.73	84.48
Trading Asset Securities	330	300.14	-	-	0.83	0.18
Cash & Short-Term Investments	665.73	867.3	166.78	156.74	218.57	84.66
Cash Growth	229.40%	420.01%	6.40%	-28.29%	158.18%	118.62%
Accounts Receivable	524.27	249.2	244.82	157.4	181.05	164.82
Other Receivables	19.35	33.98	17.46	18.59	12.21	7.45
Receivables	543.63	283.17	262.29	175.99	193.26	172.27
Inventory	472.71	522.6	242.01	198.38	104.24	118.48
Other Current Assets	47.56	54.21	59.1	36.99	96.64	46.9
Total Current Assets	1,730	1,727	730.18	568.1	612.7	422.31
Property, Plant & Equipment	409.86	416.88	433.02	405.92	254.98	115.07
Goodwill	0.02	0.02	-	-	-	-
Other Intangible Assets	62.4	63.07	59.76	61.14	50.85	51.97
Long-Term Deferred Tax Assets	12.69	11.66	8.86	4.71	6.06	4.21
Long-Term Deferred Charges	1.56	1.62	2.61	3.91	4.63	3.66
Other Long-Term Assets	33.48	4.82	2.33	7.66	8.61	1.87
Total Assets	2,250	2,225	1,237	1,051	937.82	599.09

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	198.46	168.29	113.11	57.42	66.02	61.24
Accrued Expenses	29.56	29.31	17.01	27.88	40.8	19.89
Short-Term Debt	229.84	222.71	173.39	141.53	159.28	100.11
Current Portion of Long-Term Debt	0.8	5.19	7.29	0.28	10.11	-
Current Portion of Leases	0.96	0.95	3.08	3.37	5.02	0.33
Current Income Taxes Payable	11.14	4.51	3.09	0.34	3.06	2.32
Current Unearned Revenue	11.67	51.08	27.44	30.44	35.35	20.33
Other Current Liabilities	17.01	9.77	14.12	75.38	53.51	9
Total Current Liabilities	499.45	491.82	358.53	336.64	373.14	213.23
Long-Term Debt	-	22.44	106.37	72.9	40.5	-
Long-Term Leases	-	0.49	3.48	-	5.14	-
Long-Term Unearned Revenue	17.11	10.48	11.36	11.91	2.03	2.55
Long-Term Deferred Tax Liabilities	0.24	0.37	1.22	0.5	1.94	0.07
Other Long-Term Liabilities	-	-	-	-	1.66	1
Total Liabilities	516.8	525.6	480.96	421.95	424.41	216.84

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	143.5	143.5	107.6	107.6	107.6	105.79
Additional Paid-In Capital	956.02	955.24	189.71	-	-	87.29
Retained Earnings	630.24	599.04	458.48	521.9	405.82	187.69
Total Common Equity	1,730	1,698	755.79	629.5	513.42	380.77
Minority Interest	3.09	1.97	-	-	-	1.48
Shareholders' Equity	1,733	1,700	755.79	629.5	513.42	382.25
Total Liabilities & Equity	2,250	2,225	1,237	1,051	937.82	599.09

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	231.6	251.78	293.62	218.09	220.05	100.44
Net Cash (Debt)	434.13	615.52	-126.83	-61.34	-1.48	-15.79
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	3.32	5.43	-1.18	-0.57	-0.01	-0.15
Filing Date Shares Outstanding	143.5	143.5	107.6	143.5	107.6	106.16
Total Common Shares Outstanding	143.5	143.5	107.6	143.5	107.6	106.16
Working Capital	1,230	1,235	371.64	231.46	239.56	209.08
Book Value Per Share	12.05	11.83	7.02	4.39	4.77	3.59
Tangible Book Value	1,667	1,635	696.03	568.36	462.57	328.8
Tangible Book Value Per Share	11.62	11.39	6.47	3.96	4.30	3.10
Buildings	164.75	164.75	72.03	69.95	25.06	25.61
Machinery	338.35	317.67	128.96	122.66	103.98	92.27
Construction In Progress	16.76	25.2	291.81	262.7	155.85	27.76

Data Source: S&P Global Market Intelligence Last updated: Aug 23, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 13, 2026

Data Sources Report a data error